These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21362127)

  • 1. Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population.
    Mohl A; Boda Z; Jager R; Losonczy H; Marosi A; Masszi T; Nagy E; Nemes L; Obser T; Oyen F; Radványi G; Schlammadinger Á; Szélessy ZS; Várkonyi A; Vezendy K; Vilimi B; Schneppenheim R; Bodó I
    J Thromb Haemost; 2011 May; 9(5):945-52. PubMed ID: 21362127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.
    Bowman M; Tuttle A; Notley C; Brown C; Tinlin S; Deforest M; Leggo J; Blanchette VS; Lillicrap D; James P;
    J Thromb Haemost; 2013 Mar; 11(3):512-20. PubMed ID: 23311757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.
    Yadegari H; Driesen J; Pavlova A; Biswas A; Hertfelder HJ; Oldenburg J
    Thromb Haemost; 2012 Oct; 108(4):662-71. PubMed ID: 22871923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients.
    Kasatkar P; Shetty S; Ghosh K
    PLoS One; 2014; 9(3):e92575. PubMed ID: 24675615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary.
    Mohl A; Marschalek R; Masszi T; Nagy E; Obser T; Oyen F; Sallai K; Bodó I; Schneppenheim R
    J Thromb Haemost; 2008 Oct; 6(10):1729-35. PubMed ID: 18665926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the mutation spectrum in a Pakistani cohort of type 3 von Willebrand disease.
    Ahmed S; Yadegari H; Naz A; Biswas A; Budde U; Saqlain N; Amanat S; Tariq S; Raziq F; Masood S; Pavlova A; Shamsi TS; Oldenburg J
    Haemophilia; 2019 Nov; 25(6):1035-1044. PubMed ID: 31532876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations.
    Jokela V; Lassila R; Szanto T; Joutsi-Korhonen L; Armstrong E; Oyen F; Schneppenheim S; Schneppenheim R
    Haemophilia; 2013 Nov; 19(6):e344-8. PubMed ID: 23834637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel mutations identified in a type 3 von Willebrand disease patient.
    Ouyang W; Yu Z; Yin J; Su J; Yang C; Ruan C
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):909-11. PubMed ID: 24914743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
    Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
    Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients.
    Solimando M; Baronciani L; La Marca S; Cozzi G; Asselta R; Canciani MT; Federici AB; Peyvandi F
    Am J Hematol; 2012 Sep; 87(9):870-4. PubMed ID: 22674667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients.
    Gupta PK; Saxena R; Adamtziki E; Budde U; Oyen F; Obser T; Schneppenheim R
    Blood Cells Mol Dis; 2008; 41(2):219-22. PubMed ID: 18485763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe, recessive type 1 is a discrete form of von Willebrand disease: the lesson learned from the c.1534-3C>A von Willebrand factor mutation.
    Casonato A; Cattini MG; Barbon G; Daidone V; Pontara E
    Thromb Res; 2015 Sep; 136(3):682-6. PubMed ID: 26251079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):277-95. PubMed ID: 16959681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic basis of von Willebrand disease.
    Goodeve AC
    Blood Rev; 2010 May; 24(3):123-34. PubMed ID: 20409624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterisation of mutations associated with von Willebrand disease in a Turkish patient cohort.
    Hampshire DJ; Abuzenadah AM; Cartwright A; Al-Shammari NS; Coyle RE; Eckert M; Al-Buhairan AM; Messenger SL; Budde U; Gürsel T; Ingerslev J; Peake IR; Goodeve AC
    Thromb Haemost; 2013 Aug; 110(2):264-74. PubMed ID: 23702511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.
    Ahmad F; Budde U; Jan R; Oyen F; Kannan M; Saxena R; Schneppenheim R
    Thromb Haemost; 2013 Apr; 109(4):652-60. PubMed ID: 23407766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients.
    Baronciani L; Cozzi G; Canciani MT; Peyvandi F; Srivastava A; Federici AB; Mannucci PM
    Blood Cells Mol Dis; 2003; 30(3):264-70. PubMed ID: 12737944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mutation spectrum associated with type 3 von Willebrand disease in a cohort of patients from the north west of England.
    Sutherland MS; Keeney S; Bolton-Maggs PH; Hay CR; Will A; Cumming AM
    Haemophilia; 2009 Sep; 15(5):1048-57. PubMed ID: 19601990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-3 von Willebrand disease in India-Clinical spectrum and molecular profile.
    Elayaperumal S; Fouzia NA; Biswas A; Nair SC; Viswabandya A; George B; Abraham A; Oldenburg J; Edison ES; Srivastava A
    Haemophilia; 2018 Nov; 24(6):930-940. PubMed ID: 29984440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.